Health Care & Life Sciences » Pharmaceuticals | Elite Pharmaceuticals Inc.

Elite Pharmaceuticals Inc. | Cash Flow

Fiscal year is April-March. All values USD Thousands.
2014
2015
2016
2017
2018
2019
Net Income before Extraordinaries
41,260.90
5,220.60
683.00
3,811.20
3,673.20
9,279.30
Depreciation, Depletion & Amortization
453.70
581.90
652.30
700.40
996.40
1,256.90
Other Funds
36,653.30
20,062.80
4,608.20
7,838.60
3,060.10
2,171.80
Funds from Operations
4,153.90
14,260.30
4,638.90
3,327.10
5,736.90
5,850.60
Changes in Working Capital
8.00
842.90
1,873.50
4,556.80
927.70
942.20
Net Operating Cash Flow
4,161.90
15,103.20
2,765.40
7,883.90
4,809.20
6,792.80
Capital Expenditures
560.40
1,996.90
1,948.80
1,104.90
274.80
Purchase/Sale of Investments
2.80
4,876.10
-
0.10
2.50
Net Investing Cash Flow
557.70
2,879.20
1,948.80
1,105.00
277.30
Issuance/Reduction of Debt, Net
530.30
1,383.30
478.90
1,339.80
632.50
Net Financing Cash Flow
11,347.30
12,746.40
8,762.20
8,071.40
1,671.10
Net Change in Cash
6,572.80
522.40
4,048.00
917.50
3,415.50
Free Cash Flow
4,664.10
17,068.30
4,684.20
8,981.40
4,990.10
Change in Capital Stock
10,820.10
14,021.10
9,241.10
9,411.10
2,303.60
Miscellaneous Funds
55.00
-
-
-
-

About Elite Pharmaceuticals

View Profile
Address
165 Ludlow Avenue
Northvale New Jersey 07647
United States
Employees -
Website http://www.elitepharma.com
Updated 07/08/2019
Elite Pharmaceuticals, Inc. is a pharmaceutical company, which is engaged in the development and manufacture of oral, controlled-release products, using proprietary know-how and technology, as it relates to abuse resistant products. Its strategy includes off-patent drug products for life cycle management and developing generic versions of controlled-release drug products. The company was founded on October 1, 1997 and is headquartered in Northvale, NJ.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.